These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9041672)

  • 1. A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge.
    Fischer L; Le Gros FX; Mason PW; Paoletti E
    Vaccine; 1997 Jan; 15(1):90-6. PubMed ID: 9041672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV).
    Rohde J; Schirrmeier H; Granzow H; Rziha HJ
    Vaccine; 2011 Nov; 29(49):9256-64. PubMed ID: 22001119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
    Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant canine adenovirus type 2 expressing rabbit hemorrhagic disease virus VP60 protein provided protection against RHD in rabbits.
    Jiang Q; Yu Z; Liu JS; Kong DS; Guo DC; Quan CS; Li BT; Hu XL; Qu L
    Vet Microbiol; 2018 Jan; 213():15-20. PubMed ID: 29291998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus.
    Bertagnoli S; Gelfi J; Petit F; Vautherot JF; Rasschaert D; Laurent S; Le Gall G; Boilletot E; Chantal J; Boucraut-Baralon C
    Vaccine; 1996 Apr; 14(6):506-10. PubMed ID: 8782348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-based oral vaccine for rabbit hemorrhagic disease.
    Wang X; Qiu L; Hao H; Zhang W; Fu X; Zhang H; He S; Zhang S; Du E; Yang Z
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):277-82. PubMed ID: 22154735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and immunogenicity of novel bivalent virus-like particles bearing VP60 genes of classic RHDV(GI.1) and RHDV2(GI.2).
    Qi R; Miao Q; Zhu J; Tang J; Tang A; Wang X; Dong D; Guo H; Liu G
    Vet Microbiol; 2020 Jan; 240():108529. PubMed ID: 31902498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein.
    Bertagnoli S; Gelfi J; Le Gall G; Boilletot E; Vautherot JF; Rasschaert D; Laurent S; Petit F; Boucraut-Baralon C; Milon A
    J Virol; 1996 Aug; 70(8):5061-6. PubMed ID: 8764013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus.
    Castañón S; Marín MS; Martín-Alonso JM; Boga JA; Casais R; Humara JM; Ordás RJ; Parra F
    J Virol; 1999 May; 73(5):4452-5. PubMed ID: 10196345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codon optimization of the rabbit hemorrhagic disease virus (RHDV) capsid gene leads to increased gene expression in Spodoptera frugiperda 9 (Sf9) cells.
    Gao J; Meng C; Chen Z; Li C; Liu G
    J Vet Sci; 2013; 14(4):441-7. PubMed ID: 23820215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembly, antigenicity, and immunogenicity of the rabbit haemorrhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus.
    Nagesha HS; Wang LF; Hyatt AD; Morrissy CJ; Lenghaus C; Westbury HA
    Arch Virol; 1995; 140(6):1095-1108. PubMed ID: 7541982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV.
    Pérez-Filgueira DM; Resino-Talaván P; Cubillos C; Angulo I; Barderas MG; Barcena J; Escribano JM
    Virology; 2007 Aug; 364(2):422-30. PubMed ID: 17434554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immune responses in rabbits induced by a suicidal DNA vaccine of the VP60 gene of rabbit hemorrhagic disease virus.
    Cheng Y; Chen Z; Li C; Meng C; Wu R; Liu G
    Antiviral Res; 2013 Mar; 97(3):227-31. PubMed ID: 23295353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination with a gene encoding VP60 elicited protective immunity against rabbit hemorrhagic disease virus.
    Yuan D; Qu L; Liu J; Guo D; Jiang Q; Lin H; Si C
    Vet Microbiol; 2013 May; 164(1-2):1-8. PubMed ID: 23419819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease.
    Torres JM; Ramírez MA; Morales M; Bárcena J; Vázquez B; Espuña E; Pagès-Manté A; Sánchez-Vizcaíno JM
    Vaccine; 2000 Sep; 19(2-3):174-82. PubMed ID: 10930670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a VLP-based vaccine in silkworm pupae against rabbit hemorrhagic disease virus.
    Zheng X; Wang S; Zhang W; Liu X; Yi Y; Yang S; Xia X; Li Y; Zhang Z
    Int Immunopharmacol; 2016 Nov; 40():164-169. PubMed ID: 27598862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector.
    Fernández-Fernández MR; Mouriño M; Rivera J; Rodríguez F; Plana-Durán J; García JA
    Virology; 2001 Feb; 280(2):283-91. PubMed ID: 11162842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease.
    Torres JM; Sánchez C; Ramírez MA; Morales M; Bárcena J; Ferrer J; Espuña E; Pagès-Manté A; Sánchez-Vizcaíno JM
    Vaccine; 2001 Aug; 19(31):4536-43. PubMed ID: 11483281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus.
    Gromadzka B; Szewczyk B; Konopa G; Fitzner A; Kesy A
    Acta Biochim Pol; 2006; 53(2):371-6. PubMed ID: 16733562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit Hemorrhagic Disease Virus Variant Recombinant VP60 Protein Induces Protective Immunogenicity.
    Yang DK; Kim HH; Nah JJ; Song JY
    J Microbiol Biotechnol; 2015 Nov; 25(11):1960-5. PubMed ID: 26198122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.